Robert P. Gasparini
Director/Board Member presso HEALTHLYNKED CORP.
Patrimonio netto: 164 171 $ in data 31/03/2024
Profilo
Robert P.
Gasparini is currently the Director at CirculoGene Theranostics, Inc. and an Independent Director at Healthlynked Corp.
He previously held positions as President, Director & Chief Scientific Officer at NeoGenomics, Inc., Director-Genetics Division at US Pathology Labs, Inc., Technical Director-Genetics at Tufts University, Assistant Director-Cytogenetics Laboratory at Prenatal Diagnostic Center, and Manager-Worldwide & Strategic Marketing at Ventana Medical Systems, Inc. Gasparini holds a graduate degree from Quinnipiac University and an undergraduate degree from the University of Connecticut.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HEALTHLYNKED CORP
1.08% | 27/09/2023 | 2 880 191 ( 1.08% ) | 164 171 $ | 31/03/2024 |
Posizioni attive di Robert P. Gasparini
| Società | Posizione | Inizio |
|---|---|---|
| HEALTHLYNKED CORP. | Director/Board Member | 30/04/2019 |
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Director/Board Member | 08/12/2022 |
Precedenti posizioni note di Robert P. Gasparini
| Società | Posizione | Fine |
|---|---|---|
| NEOGENOMICS, INC. | President | 04/08/2014 |
US Pathology Labs, Inc.
 US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | President | 01/01/2014 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Sales & Marketing | 01/01/2001 |
| Prenatal Diagnostic Center | Corporate Officer/Principal | 01/01/1997 |
| Tufts University | Corporate Officer/Principal | 01/01/1993 |
Formazione di Robert P. Gasparini
| Quinnipiac University | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| HEALTHLYNKED CORP. | Technology Services |
| Aziende private | 4 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Services |
| Prenatal Diagnostic Center | |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
- Borsa valori
- Insiders
- Robert P. Gasparini
